🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/03/1989 | 0,0652 USD |
| 29/11/1988 | 0,0588 USD |
| 29/08/1988 | 0,0469 USD |
| 03/06/1988 | 0,0509 USD |
| 29/02/1988 | 0,0509 USD |
| 01/12/1987 | 0,0424 USD |
| 28/08/1987 | 0,0424 USD |
| 02/06/1987 | 0,0292 USD |
| 02/03/1987 | 0,0292 USD |
| 02/12/1986 | 0,0292 USD |
| 02/09/1986 | 0,0292 USD |
| 03/06/1986 | 0,0239 USD |
| 27/02/1986 | 0,0239 USD |
| 03/12/1985 | 0,0239 USD |
| 30/08/1985 | 0,0212 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 03/11/2025 | 85,77 | 86,10 | 82,34 | 82,49 | -4,06% | 4,38% | 13.875.800 |
| 31/10/2025 | 85,42 | 86,46 | 84,56 | 85,98 | -0,35% | 2,22% | 12.385.000 |
| 30/10/2025 | 84,62 | 87,30 | 83,30 | 86,28 | -0,35% | 4,73% | 16.678.800 |
| 29/10/2025 | 86,95 | 87,84 | 86,07 | 86,58 | -0,52% | 2,04% | 10.921.900 |
| 28/10/2025 | 88,11 | 88,11 | 86,93 | 87,03 | -1,10% | 1,34% | 8.345.900 |
| 27/10/2025 | 87,51 | 88,30 | 87,03 | 88,00 | +0,58% | 1,45% | 7.226.600 |
| 24/10/2025 | 87,33 | 88,06 | 87,11 | 87,49 | +0,36% | 1,09% | 7.902.100 |
| 23/10/2025 | 87,56 | 88,11 | 86,91 | 87,18 | -0,49% | 1,37% | 7.687.500 |
| 22/10/2025 | 87,68 | 88,79 | 87,01 | 87,61 | -0,01% | 2,03% | 10.926.300 |
| 21/10/2025 | 86,96 | 87,67 | 86,23 | 87,62 | +1,51% | 1,66% | 9.852.400 |
| 20/10/2025 | 85,25 | 87,00 | 85,03 | 86,32 | +1,80% | 2,31% | 8.611.800 |
| 17/10/2025 | 83,28 | 84,89 | 83,16 | 84,79 | +1,04% | 2,08% | 10.758.900 |
| 16/10/2025 | 84,41 | 85,50 | 83,60 | 83,92 | -0,23% | 2,25% | 11.709.100 |
| 15/10/2025 | 84,19 | 84,69 | 83,61 | 84,11 | -0,70% | 1,28% | 9.168.700 |
| 14/10/2025 | 85,38 | 85,68 | 84,15 | 84,70 | -1,17% | 1,79% | 9.675.000 |
| 13/10/2025 | 85,66 | 86,46 | 85,24 | 85,70 | -0,34% | 1,42% | 6.553.900 |
| 10/10/2025 | 87,94 | 88,24 | 85,92 | 85,99 | -1,73% | 2,64% | 11.230.700 |
| 09/10/2025 | 86,96 | 87,80 | 86,64 | 87,50 | +1,27% | 1,33% | 10.938.200 |
| 08/10/2025 | 87,93 | 87,93 | 86,20 | 86,40 | -1,38% | 1,97% | 9.696.200 |
| 07/10/2025 | 88,67 | 88,94 | 87,14 | 87,61 | -1,34% | 2,03% | 9.449.100 |
| 06/10/2025 | 88,83 | 90,31 | 88,55 | 88,80 | -0,44% | 1,98% | 11.648.300 |
| 03/10/2025 | 89,63 | 90,70 | 88,10 | 89,19 | -0,36% | 2,90% | 12.970.600 |
| 02/10/2025 | 89,95 | 91,00 | 88,22 | 89,51 | -0,69% | 3,09% | 14.575.400 |
| 01/10/2025 | 85,19 | 90,75 | 85,19 | 90,13 | +7,39% | 6,53% | 33.460.900 |
| 30/09/2025 | 78,42 | 84,00 | 78,40 | 83,93 | +6,81% | 7,14% | 21.636.600 |
| 29/09/2025 | 78,60 | 78,80 | 78,03 | 78,58 | +0,03% | 0,98% | 12.739.000 |
| 26/09/2025 | 78,76 | 78,96 | 77,69 | 78,56 | +1,24% | 1,61% | 12.205.400 |
| 25/09/2025 | 79,78 | 79,88 | 77,58 | 77,60 | -2,60% | 2,88% | 14.923.800 |
| 24/09/2025 | 79,90 | 80,11 | 79,33 | 79,67 | -0,36% | 0,98% | 11.804.200 |
| 23/09/2025 | 80,09 | 81,11 | 79,67 | 79,96 | -0,55% | 1,80% | 13.145.300 |